NYSE:MPLN - New York Stock Exchange, Inc. - US62548M2098 - Common Stock - Currency: USD
19.61
-9.59 (-32.84%)
The current stock price of MPLN is 19.61 USD. In the past month the price increased by 23.18%. In the past year, price decreased by -55.83%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 35.42 | 35.94B | ||
DOCS | DOXIMITY INC-CLASS A | 56.02 | 13.46B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.19B | ||
CERT | CERTARA INC | 31.74 | 1.99B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.92B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 14.53 | 1.77B | ||
PHR | PHREESIA INC | N/A | 1.54B | ||
SDGR | SCHRODINGER INC | N/A | 1.53B | ||
EVH | EVOLENT HEALTH INC - A | 15.86 | 1.22B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 989.63M | ||
HSTM | HEALTHSTREAM INC | 49.05 | 984.37M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.62 | 770.25M |
Multiplan Corp is a US-based company operating in Health Care Technology industry. The company is headquartered in New York City, New York and currently employs 2,800 full-time employees. The company went IPO on 2020-02-10. MultiPlan Corporation is a provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the United States healthcare industry. The firm interprets customer’s needs and customizes solutions that combine its payment and revenue integrity, network-based, analytics-based, and data and decision science services. Through its data and technology platform, the Company provides out-of-network cost management, payment and revenue integrity, data and decision science, business-to-business (B2B) healthcare payments and other services to the payors of healthcare, which are primarily health insurers and their administrative-services-only (ASO) platforms, self-insured employers, federal and state government-sponsored health plans and other health plan sponsors, and, indirectly, the plan members who are the consumers of healthcare services. The firm is a partner to over 700 healthcare payors, brokers, and others.
MULTIPLAN CORP
115 Fifth Avenue
New York City NEW YORK 10019 US
CEO: Mark H. Tabak
Employees: 2800
Company Website: https://www.multiplan.us/
Investor Relations: https://investors.multiplan.us/
Phone: 12127802000
The current stock price of MPLN is 19.61 USD. The price decreased by -32.84% in the last trading session.
The exchange symbol of MULTIPLAN CORP is MPLN and it is listed on the New York Stock Exchange, Inc. exchange.
MPLN stock is listed on the New York Stock Exchange, Inc. exchange.
9 analysts have analysed MPLN and the average price target is 11.05 USD. This implies a price decrease of -43.65% is expected in the next year compared to the current price of 19.61. Check the MULTIPLAN CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MULTIPLAN CORP (MPLN) has a market capitalization of 317.09M USD. This makes MPLN a Small Cap stock.
MULTIPLAN CORP (MPLN) currently has 2800 employees.
The Revenue of MULTIPLAN CORP (MPLN) is expected to grow by 1.16% in the next year. Check the estimates tab for more information on the MPLN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MPLN does not pay a dividend.
MULTIPLAN CORP (MPLN) will report earnings on 2025-05-06.
MULTIPLAN CORP (MPLN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-66.19).
The outstanding short interest for MULTIPLAN CORP (MPLN) is 5.02% of its float. Check the ownership tab for more information on the MPLN short interest.
ChartMill assigns a technical rating of 7 / 10 to MPLN. When comparing the yearly performance of all stocks, MPLN is one of the better performing stocks in the market, outperforming 95.1% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to MPLN. There are concerns on the financial health of MPLN while its profitability can be described as average.
Over the last trailing twelve months MPLN reported a non-GAAP Earnings per Share(EPS) of -66.19. The EPS decreased by -1003.17% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -28.94% | ||
ROE | -741.59% | ||
Debt/Equity | 21.73 |
ChartMill assigns a Buy % Consensus number of 78% to MPLN. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 86.35% and a revenue growth 1.16% for MPLN